Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SKF-86002 is an effective inhibitor of p38 MAP kinase (IC50: 0.5-1 uM); inhibits LPS-induced IL-1 and TNF-α production in human monocytes (IC50: 1 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 31.00 | |
2 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 76.00 | |
10 mg | In stock | $ 128.00 | |
25 mg | In stock | $ 238.00 | |
50 mg | In stock | $ 353.00 | |
100 mg | In stock | $ 522.00 | |
500 mg | In stock | $ 1,120.00 |
Description | SKF-86002 is an effective inhibitor of p38 MAP kinase (IC50: 0.5-1 uM); inhibits LPS-induced IL-1 and TNF-α production in human monocytes (IC50: 1 μM). |
Targets&IC50 | IL-1:1 μM, TNF-α:1 μM, p38 MAP kinase:0.5-1 μM |
Synonyms | SKF86002 |
Molecular Weight | 297.35 |
Formula | C16H12FN3S |
CAS No. | 72873-74-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Slightly soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SKF-86002 72873-74-6 Apoptosis MAPK TNF p38 MAPK inhibit acid Inhibitor lipoxygenase metabolism arachidonic anti-arthritic cyclooxygenase SKF 86002 5-lipoxygenase anti-inflammatory analgesic SKF86002 inhibitor